Harvard Apparatus Regenerative Technology, Inc. financial data

Symbol
HRGN on OTC
Location
Holliston, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 07 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 192% % 105%
Quick Ratio 4% % -1.2%
Debt-to-equity 65% %
Return On Equity -344% % 44%
Return On Assets -208% % -6.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17,168,979 shares 7.9%
Common Stock, Shares, Outstanding 17,168,979 shares 7.9%
Entity Public Float $28,300,000 USD -16%
Common Stock, Value, Issued $172,000 USD 8.2%
Weighted Average Number of Shares Outstanding, Basic 17,033,109 shares 13%
Weighted Average Number of Shares Outstanding, Diluted 15,017,591 shares 8.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $743,000 USD 108%
Cost of Revenue $622,000 USD 60%
Research and Development Expense $2,224,000 USD -17%
Selling and Marketing Expense $449,000 USD -91%
General and Administrative Expense $4,345,000 USD -14%
Costs and Expenses $7,325,000 USD -4.2%
Operating Income (Loss) $6,582,000 USD 20%
Nonoperating Income (Expense) $56,000 USD
Net Income (Loss) Attributable to Parent $6,526,000 USD 21%
Earnings Per Share, Basic 0 USD/shares 33%
Earnings Per Share, Diluted 0 USD/shares 16%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,319,000 USD -63%
Cash, Cash Equivalents, and Short-term Investments $3,600,000 USD 140%
Accounts Receivable, after Allowance for Credit Loss, Current $3,000 USD 200%
Inventory, Net $22,000 USD -81%
Assets, Current $1,627,000 USD -59%
Property, Plant and Equipment, Net $7,000 USD -46%
Operating Lease, Right-of-Use Asset $221,000 USD -31%
Assets $2,546,000 USD -52%
Accounts Payable, Current $313,000 USD -38%
Employee-related Liabilities, Current $116,000 USD 5.5%
Contract with Customer, Liability, Current $128,000 USD
Liabilities, Current $876,000 USD -30%
Operating Lease, Liability, Noncurrent $116,000 USD -48%
Liabilities $992,000 USD -33%
Accumulated Other Comprehensive Income (Loss), Net of Tax $9,000 USD 62%
Retained Earnings (Accumulated Deficit) $104,870,000 USD -6.6%
Stockholders' Equity Attributable to Parent $1,554,000 USD -60%
Liabilities and Equity $2,546,000 USD -52%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $758,000 USD 21%
Net Cash Provided by (Used in) Financing Activities $0 USD -100%
Common Stock, Shares Authorized 60,000,000 shares 0%
Common Stock, Shares, Issued 17,168,979 shares 7.9%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $758,000 USD -374%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,000 USD -78%
Deferred Tax Assets, Valuation Allowance $26,814,000 USD 7.7%
Deferred Tax Assets, Gross $26,894,000 USD 7.9%
Operating Lease, Liability $224,000 USD -32%
Depreciation $2,000 USD -67%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $6,511,000 USD 20%
Lessee, Operating Lease, Liability, to be Paid $256,000 USD -36%
Property, Plant and Equipment, Gross $1,487,000 USD 0%
Operating Lease, Liability, Current $108,000 USD 2.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two $90,000 USD -32%
Lessee, Operating Lease, Liability, to be Paid, Year One $133,000 USD 3.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $32,000 USD -53%
Lessee, Operating Lease, Liability, to be Paid, Year Three $90,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $20,058 USD 6.7%
Preferred Stock, Shares Authorized 2,000,000 shares 0%
Operating Lease, Payments $145,000 USD -20%
Additional Paid in Capital $106,261,000 USD 4.1%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $80,000 USD 515%
Share-based Payment Arrangement, Expense $562,000 USD 5%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%